Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,598.00
Bid: 1,601.00
Ask: 1,602.00
Change: -168.50 (-9.54%)
Spread: 1.00 (0.062%)
Open: 1,616.50
High: 1,637.50
Low: 1,589.50
Prev. Close: 1,766.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Merrill Lynch, JPMorgan Cut Pearson To Neutral

Thu, 22nd Oct 2015 08:40

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning:
----------
FTSE 100
----------
MERRILL LYNCH CUTS PEARSON TO 'NEUTRAL' ('BUY')
----------
JPMORGAN CUTS PEARSON TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 1,080 (1,365) PENCE
----------
KEPLER CHEUVREUX CUTS PEARSON PRICE TARGET TO 1300 (1400) PENCE - 'BUY'
----------
NOMURA CUTS PEARSON PRICE TARGET TO 1100 (1280) PENCE - 'NEUTRAL'
----------
DEUTSCHE BANK CUTS PEARSON PRICE TARGET TO 950 (1045) PENCE - 'SELL'
----------
JEFFERIES RAISES RECKITT BENCKISER PRICE TARGET TO 7100 (6750) PENCE - 'BUY'
----------
LIBERUM RAISES RECKITT BENCKISER PRICE TARGET TO 6800 (6660) PENCE - 'BUY'
----------
EXANE BNP RAISES RECKITT BENCKISER PRICE TARGET TO 6900 (6600) PENCE - 'OUTPERFORM'
----------
DEUTSCHE BANK RAISES RECKITT BENCKISER PRICE TARGET TO 6500 (6400) PENCE - 'BUY'
----------
PANMURE CUTS TRAVIS PERKINS PRICE TARGET TO 1650 (1950) PENCE - 'SELL'
----------
EXANE BNP RAISES SKY PLC PRICE TARGET TO 1050 (1000) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS GLAXOSMITHKLINE PRICE TARGET TO 1400 (1420) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS BHP BILLITON PRICE TARGET TO 1300 (1360) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES ARM PRICE TARGET TO 950 (850) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS HSBC PRICE TARGET TO 640 (670) PENCE - 'NEUTRAL'
----------
FTSE 250
----------
PANMURE CUTS SIG PRICE TARGET TO 195 (226) PENCE - 'BUY'
----------
PANMURE CUTS SENIOR PLC TO 'HOLD' ('BUY') - TARGET 293 (402) PENCE
----------
JPMORGAN CUTS ACACIA MINING PRICE TARGET TO 300 (310) PENCE - 'OVERWEIGHT'
----------
EXANE BNP CUTS HOME RETAIL PRICE TARGET TO 115 (145) PENCE - 'UNDERPERFORM'
----------
DEUTSCHE BANK CUTS HOME RETAIL PRICE TARGET TO 130 (150) PENCE - 'HOLD'
----------
NOMURA CUTS HOME RETAIL PRICE TARGET TO 170 (200) PENCE - 'BUY'
----------
HSBC CUTS HOME RETAIL PRICE TARGET TO 1,800 (2,350) PENCE - 'BUY'
----------
HSBC CUTS PENNON GROUP PRICE TARGET TO 9,150 (9,500) PENCE - 'BUY'
----------
GOLDMAN RAISES TED BAKER PRICE TARGET TO 3560 (3530) PENCE - 'BUY'
----------
GOLDMAN RAISES SHAWBROOK PRICE TARGET TO 390 (370) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES PROVIDENT FINANCIAL PRICE TARGET TO 3370 (2970) PENCE - NEUTRAL
----------
GOLDMAN RAISES POLYMETAL PRICE TARGET TO 620 (570) PENCE - 'BUY'
----------
GOLDMAN INITIATES CENTAMIN WITH 'CONVICTION BUY LIST'
----------
TRADERS: CREDIT SUISSE CUTS HAYS TO 'NEUTRAL' ('OUTPERFORM')
----------
MAIN MARKET AND AIM
----------
NUMIS RAISES MOTHERCARE TO 'BUY' ('ADD') - TARGET 300 (320) PENCE
----------
NUMIS CUTS CAMBIAN PRICE TARGET TO 320 (380) PENCE - 'BUY'
----------
JPMORGAN RAISES LONMIN PRICE TARGET TO 35 (30) PENCE - 'OVERWEIGHT'
----------
GOLDMAN CUTS ARROW GLOBAL PRICE TARGET TO 360 (380) PENCE - 'BUY'
----------
TRADERS: CREDIT SUISSE CUTS STHREE TO 'NEUTRAL' ('OUTPERFORM')
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more
27 May 2024 06:00

US, European nations consider vaccinating workers exposed to bird flu

CHICAGO/LONDON, May 27 (Reuters) - The United States and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines that could be used to protect at-risk poultry and dairy workers, veterinarians and lab technicians, government officials said, moves influenza experts say could curb the threat of a pandemic.

Read more
24 May 2024 15:19

London close: Stocks mixed after disappointing retail sales data

(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted to a larger-than-expected drop in UK retail sales.

Read more
24 May 2024 08:55

LONDON MARKET OPEN: FTSE 100 falls; retail sales plunge in April

(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.

Read more
24 May 2024 08:36

TOP NEWS: GSK celebrates Illinois jury verdict in Valadez case

(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Zantac case to go to trial.

Read more
24 May 2024 07:52

LONDON BRIEFING: UK retail sales fall amid wet April; Co-Op Bank deal

(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.

Read more
24 May 2024 07:30

Jury rules in favour of GSK in Zantac trial

(Sharecast News) - A court in Illinois has ruled in favour of GSK in the first Zantac case to go to trial, the UK drugs giant confirmed on Friday.

Read more
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.